| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |